Case Based Peer Perspectives

Key opinion leader Andrew Lipsky, MD, reviews the case of a 72-year-old man with relapsed/refractory chronic lymphocytic leukemia and highlights the evolving treatment landscape of targeted therapy in this setting.

Expert perspectives on the current treatment paradigm for patients diagnosed with locally advanced or metastatic urothelial carcinoma.

Leslie Randall, MD, MAS, presents the case of a patient with BRCA-mutated ovarian cancer and provides insights on the evolving treatment landscape.

Expert oncologist Alicia Morgans, MD, MPH, reviews the case of a 75-year-old man with metastatic castration-resistant prostate cancer and discusses appropriate treatment strategies in this setting.

Melissa Alsina, MD introduces the case of a patient with newly diagnosed multiple myeloma, discusses best practices for treating transplant-not-preferred patients, and engages with emergent trial data.

Expert oncologist Matthew Powell, MD, reviews the case of a woman with endometroid adenocarcinoma and considers optimal treatment strategies in this setting.

Natalie Callander, MD, presents the case of a patient with transplant-preferred newly diagnosed multiple myeloma and reviews treatment paradigms and clinical trial data.

Catherine C. Coombs, MD, presents a patient case and provides clinical insights on evolving treatment paradigms for patients with relapsed/refractory CLL.

Expert gynecologic oncologist Ritu Salani, MD, MBA, reviews a case of recurrent endometrial cancer to highlight treatment approaches and management strategies in this setting.

Expert oncologist Kevin Kalinsky, MD, centers discussion on a patient case of HR+/HER2-low metastatic breast cancer to highlight current treatment options and best practices.

Matthew R. Smith, MD, PhD presents a nonmetastatic castration-resistant prostate cancer (CRPC) patient case, discusses how clinical trial data informs his treatment selection, and shares clinical pearls for community oncologists treating patients with CRPC.

Rana McKay, MD presents a metastatic castration-resistant prostate cancer patient case, discusses standards of care in the prostate cancer treatment landscape, and shares emergent clinical trial data.

Nelson J. Chao, MD, an expert on graft-vs-host disease, discusses a profile of a patient with GVHD, and analyzes the evolving treatment landscape.

Abdulraheem Yacoub, MD, presents the case of a 68-year-old woman with myelofibrosis and details the evolving treatment landscape.

John Allan, MD, presents the case of a 72-year-old woman with chronic lymphocytic leukemia, and discusses the treatment landscape for patients with newly diagnosed CLL.

Monty Pal, MD, FASCO, presents a case of a 71-year-old patient with relapsed-refractory mRCC and discusses his data-informed rationale for treatment selection and sequencing in the treatment landscape of metastatic renal cell carcinoma.

Centering discussion on a patient case of metastatic breast cancer, expert oncologist Hope Rugo, MD, FASCO, highlights systemic therapy selection and best practices in this setting.

Prithviraj Bose, MD presents a polycythemia vera (PV) patient case, reviews the biology of PV, and shares how existing and emergent trial data inform treatment selection and patient monitoring for his patients.

Yi-Bin Chen, MD, presents the case of a 48-year-old man with graft-vs-host disease, and discusses the overall treatment landscape for GVHD.

Chandler Park, MD presents a renal cell carcinoma (RCC) patient case, discusses current standards of care in the RCC treatment landscape, and analyses emergent data from RCC clinical trials.

Hussein Tawbi, MD, PhD shares a patient case study of BRAF-mutant metastatic melanoma before discussing standards of care for such patients in the first-line systemic therapy setting, effective treatment sequencing and adverse event management strategies, and current unmet needs in the field.

Expert oncologist Marina Chiara Garassino, MD, reviews the case of a 72-year-old woman with advanced stage NSCLC and considers optimal treatment pathways.

Peter Voorhees, MD, presents the case of a 63-year-old man with R/R multiple myeloma and discusses the potential role of non-BCMA-targeting bispecifics in the treatment landscape for multiple myeloma.

Esteemed medical oncologist Matthew Galsky, MD, discusses the case of a 55-year-old man with muscle-invasive bladder cancer (MIBC) and reviews the options for treatment in the adjuvant setting.

Robert Holloway, MD, presents a patient case of metastatic endometrial cancer and discusses the systemic therapy options and recommended guidelines in this setting.

Shaji Kumar, MD, presents the case of a 63-year-old woman with R/R multiple myeloma and discusses how recent data updates of bispecifics influence treatment decision-making for patients.

Expert oncologist Terence Friedlander, MD, discusses the case of a 75-year-old woman with muscle-invasive bladder cancer and reviews the options for treatment in the adjuvant setting.

Expert oncologist Jason Porter, MD, centers discussion on a patient case of non–small cell lung cancer and highlights novel treatment modalities in this setting.

Eric Jonasch, MD, presents the case of a 72-year-old male with advanced renal cell carcinoma (RCC) and discusses how recent data updates influence treatment decision-making.

Centering his discussion on a patient case of metastatic melanoma, expert oncologist Sajeve Thomas, MD, reflects on the current treatment paradigm and highlights best practices in care.